ARTV · Artiva Biotherapeutics, Inc.
Market Cap
$552.46M
Shares
48.89M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-27 | SUBHASHIS BANERJEE | Officer | 7,818 | 2026-08-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-18 | SUBHASHIS BANERJEE | Officer | 833 | 2026-08-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-18 | Christopher P. Horan | Officer, Director | 7,500 | 2026-05-18 | Morgan Stanley Smith Barney LLC |
| 2026-05-18 | Heather Raymon | Officer, Director | 3,500 | 2026-05-18 | Morgan Stanley Smith Barney LLC |
| 2026-05-18 | Fred Aslan, M.D. | Officer, Director | 28,000 | 2026-05-18 | Morgan Stanley Smith Barney LLC |
| 2026-05-18 | Jennifer Bush | Officer, Director | 9,000 | 2026-05-18 | Morgan Stanley Smith Barney LLC |
| 2026-05-18 | Subhashis Banerjee | Officer, Director | 7,000 | 2026-05-18 | Morgan Stanley Smith Barney LLC |
| 2025-12-15 | FRED ASLAN | Director, Officer | 12,749 | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-17 | FRED ASLAN | Director, Officer | 6,375 | 2025-11-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-17 | FRED ASLAN | Director, Officer | 25,500 | 2025-10-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-08-15 | FRED ASLAN | Director, Officer | 25,500 | 2025-08-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–11 of 11 filings
Key facts
CIK
1817241
CUSIP
04317A107
13F (30d)
69 filings
69 filers
Visit website
Investor relations